Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.

Source:http://linkedlifedata.com/resource/pubmed/id/9459155

Download in:

View as

General Info

PMID
9459155